Revance Therapeutics logo
Revance Therapeutics RVNC

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics P/S Ratio 2011-2026 | RVNC

Annual P/S Ratio Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.05 19 11.6 96.3 2.35 K 171 3.92 K 1.8 K 1.68 K 815 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.92 K 2.05 1.09 K

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.27 $ 1.38 -1.08 % $ 367 M britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
500 $ 20.52 0.79 % $ 2.86 B franceFrance
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
131 $ 3.72 3.24 % $ 8.95 B australiaAustralia
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 - - $ 86.2 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
0.237 $ 2.57 -3.48 % $ 16.1 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Forte Biosciences Forte Biosciences
FBRX
181 $ 26.92 1.8 % $ 349 M usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
3.78 $ 6.22 -3.12 % $ 178 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
Fulcrum Therapeutics Fulcrum Therapeutics
FULC
0.00291 $ 7.72 -1.4 % $ 489 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Gilead Sciences Gilead Sciences
GILD
6.23 $ 138.79 -0.96 % $ 173 B usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
73.3 $ 0.56 8.45 % $ 521 K israelIsrael
Genmab A/S Genmab A/S
GMAB
15.6 $ 27.26 -1.77 % $ 17.2 B danmarkDanmark
Gossamer Bio Gossamer Bio
GOSS
2.22 $ 0.32 -7.03 % $ 73.1 M usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
1.71 $ 8.02 -2.55 % $ 6.83 B spainSpain
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
BioNTech SE BioNTech SE
BNTX
35.7 $ 88.74 -2.78 % $ 27.2 B germanyGermany
Halozyme Therapeutics Halozyme Therapeutics
HALO
6.91 $ 63.49 0.64 % $ 7.61 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
5.36 $ 1.62 -3.1 % $ 190 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
11 $ 318.56 -3.57 % $ 41.7 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
1.85 $ 27.62 -0.34 % $ 1.59 B usaUSA
iBio iBio
IBIO
151 $ 2.08 2.47 % $ 21.8 M usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
2.1 $ 6.54 -1.06 % $ 59 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
6.35 $ 4.46 -0.45 % $ 729 M britainBritain
Immutep Limited Immutep Limited
IMMP
492 $ 0.35 -3.58 % $ 1.08 B australiaAustralia